Search by Drug Name or NDC
NDC 63824-0322-90 Clearasil Ultra 0.03 g/1 Details
Clearasil Ultra 0.03 g/1
Clearasil Ultra is a TOPICAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by RB Health (US) LLC. The primary component is SALICYLIC ACID.
MedlinePlus Drug Summary
Topical salicylic acid is used to help clear and prevent pimples and skin blemishes in people who have acne. Topical salicylic acid is also used to treat skin conditions that involve scaling or overgrowth of skin cells such as psoriasis (a skin disease in which red, scaly patches form on some areas of the body), ichthyoses (inborn conditions that cause skin dryness and scaling), dandruff, corns, calluses, and warts on the hands or feet. Topical salicylic acid should not be used to treat genital warts, warts on the face, warts with hair growing from them, warts in the nose or mouth, moles, or birthmarks. Salicylic acid is in a class of medications called keratolytic agents. Topical salicylic acid treats acne by reducing swelling and redness and unplugging blocked skin pores to allow pimples to shrink. It treats other skin conditions by softening and loosening dry, scaly, or thickened skin so that it falls off or can be removed easily.
Related Packages: 63824-0322-90Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Salicylic Acid Topical
Product Information
| NDC | 63824-0322 |
|---|---|
| Product ID | 63824-322_9520273b-9733-e1a9-e053-2995a90a1370 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Clearasil Ultra |
| Proprietary Name Suffix | 5 in 1 Pads |
| Non-Proprietary Name | Salicylic Acid |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | SOLUTION |
| Route | TOPICAL |
| Active Ingredient Strength | 0.03 |
| Active Ingredient Units | g/1 |
| Substance Name | SALICYLIC ACID |
| Labeler Name | RB Health (US) LLC |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part333D |
| Listing Certified Through | 2022-12-31 |
Package
NDC 63824-0322-90 (63824032290)
| NDC Package Code | 63824-322-90 |
|---|---|
| Billing NDC | 63824032290 |
| Package | 90 SOLUTION in 1 JAR (63824-322-90) |
| Marketing Start Date | 2014-09-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |